Despite availability of current screening measures, such as transvaginal ultrasound, measurement of biomarker CA125 levels [2], or a combination of both modalities, due to the highly heterogeneous nature of ovarian cancer mortality rates remain high. Here, MUC16 is linked to ovarian cancer.